GlassScriptPhysician profile
Clinten Edmondson
NPI 1689333197
$2,294.49
in general payments reported to CMS, 2019-2025
16 companies · $524 in 2025
The $524 reported for 2025 was more than what 80% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $819 · 2023: $740 · 2024: $213 · 2025: $524.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,428 · Education: $48.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,427.94 |
| Education | $48.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Painteq LLC | $853.97 | 2022-2023 | Painteq |
| Abbvie INC. | $373.77 | 2023-2025 | |
| Vertex Pharmaceuticals Incorporated | $218.45 | 2025 | |
| Nalu Medical, INC. | $213.11 | 2023-2025 | Nalu Neurostimulation System |
| Collegium Pharmaceutical, INC. | $185.14 | 2023-2025 | Belbuca |
| Nevro Corp. | $129.33 | 2023 | Senza |
| Pfizer INC. | $66.91 | 2023-2025 | |
| Boston Scientific Corporation | $53.17 | 2023-2025 | Accolade Sr |
| Spinal Simplicity, LLC | $40.39 | 2025 | Ha Minuteman G3-R |
| Medtronic, INC. | $36.37 | 2023 | Intellis Adaptivestim |
| Sanofi-Aventis U.S. LLC | $27.53 | 2023 | |
| Convatec INC. | $24.85 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.49 | 2025 | Relistor |
| Almatica Pharma LLC | $21.63 | 2023 | Gralise |
| Si-Bone, INC. | $14.80 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hikma Pharmaceuticals USA | $12.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clinten Edmondson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.